ESC Premium Access

PSCK9 inhibition: a new horizon in LDL-C management

Event: ESC CONGRESS 2017
Topic: Lipids
Session type: Satellite Symposium
Sponsored by Sanofi and Regeneron
Date: 27 August 2017
Time: 18:30 - 20:00

Session

7 presentations in this session

Introduction - PSCK9 inhibition: a new horizon in LDL-C management.

Speaker: Professor C. Cannon (Boston, US)
Thumbnail

LDL-C exposure and atherosclerosis progression.

Speaker: Professor A. Catapano (Milan, IT)
Thumbnail

PCSK9 inhibition: the data today and tomorrow.

Speaker: Professor S. Nicholls (Melbourne, AU)
Thumbnail

Learnings and clinical insights from SPIRE.

Speaker: Doctor P. Ridker (Boston, US)
Thumbnail

Guidelines: commonalities and discrepancies.

Speaker: Doctor J. Robinson (Iowa, US)
Thumbnail

Identifying appropriate patients to treat: a case-based approach.

Speaker: Professor C. Cannon (Boston, US)
Speaker: Professor A. Catapano (Milan, IT)
Speaker: Professor S. Nicholls (Melbourne, AU)
Speaker: Doctor P. Ridker (Boston, US)
Speaker: Doctor J. Robinson (Iowa, US)
Thumbnail

Concluding remarks - PSCK9 inhibition: a new horizon in LDL-C management.

Speaker: Professor A. Catapano (Milan, IT)
Thumbnail

11 speakers from this session

Professor Christopher Paul Cannon

Cardiovascular Division, Brigham and Women?s Hospital, Harvard Medical School, Boston (United States of America)
30 presentations
0 follower

Professor Alberico Catapano

University of Milan - Department of Pharmacological Sciences and Bio, Milan (Italy)
34 presentations
3 followers

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)
34 presentations
1 follower

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)
25 presentations
2 followers

Doctor Jennifer Robinson

University of Iowa, Iowa (United States of America)
12 presentations
0 follower

Professor Christopher Paul Cannon

Cardiovascular Division, Brigham and Women?s Hospital, Harvard Medical School, Boston (United States of America)
30 presentations
0 follower

Professor Alberico Catapano

University of Milan - Department of Pharmacological Sciences and Bio, Milan (Italy)
34 presentations
3 followers

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)
34 presentations
1 follower

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)
25 presentations
2 followers

Doctor Jennifer Robinson

University of Iowa, Iowa (United States of America)
12 presentations
0 follower

Professor Alberico Catapano

University of Milan - Department of Pharmacological Sciences and Bio, Milan (Italy)
34 presentations
3 followers

This platform is supported by

logo Novo Nordisk